(Total Views: 86)
Posted On: 10/18/2022 8:40:50 AM
Post# of 27272

$SLRX News Article - Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas https://marketwirenews.com/news-releases/sala...81674.html


My Twitter: WhyteStocks